Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases.


Phosphodiesterases (PDEs) are responsible for the breakdown of intracellular cyclic nucleotides, from which PDE4 are the major cyclic AMP metabolizing isoenzymes found in inflammatory and immune cells. This generated greatest interest on PDE4 as a potential target to treat lung inflammatory diseases. For example, cigarette smoke-induced neutrophilia in BAL… (More)


  • Presentations referencing similar topics